Antithrombotic Therapy for Mechanical Circulatory Support: Time to Throw the Baby (Warfarin) Out With the Bathwater (Aspirin)?
作者信息
Kelleher Jane T, Givertz Michael M
机构信息
Harvard Medical School, Harvard-MIT Program in Health Sciences and Technology, Boston, MA (J.T.K.).
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.M.G.).
出版信息
Circ Heart Fail. 2024 Aug;17(8):e011568. doi: 10.1161/CIRCHEARTFAILURE.124.011568. Epub 2024 Jul 25.
Abstract
摘要
相似文献
1
Antithrombotic Therapy for Mechanical Circulatory Support: Time to Throw the Baby (Warfarin) Out With the Bathwater (Aspirin)?机械循环支持的抗栓治疗：是时候连婴儿（华法林）带洗澡水（阿司匹林）一起倒掉了？
Circ Heart Fail. 2024 Aug;17(8):e011568. doi: 10.1161/CIRCHEARTFAILURE.124.011568. Epub 2024 Jul 25.
2
Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm.窦性心律心力衰竭患者的抗血小板治疗与抗凝治疗对比
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003333. doi: 10.1002/14651858.CD003333.pub4.
3
Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.成人左心室辅助装置的抗血栓治疗：系统评价。
J Thromb Haemost. 2015 Jun;13(6):946-55. doi: 10.1111/jth.12948. Epub 2015 May 9.
4
Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.华法林与阿司匹林治疗心力衰竭合并窦性心律患者的风险效益比：一项荟萃分析。
Circ Heart Fail. 2013 Mar;6(2):287-92. doi: 10.1161/CIRCHEARTFAILURE.112.971697. Epub 2012 Dec 21.
5
The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.左心室辅助装置患者颅内出血后恢复抗血栓治疗的困境。
Neurocrit Care. 2020 Jun;32(3):822-827. doi: 10.1007/s12028-019-00836-y.
6
Warfarin and Aspirin Versus Warfarin Alone in Patients With HeartMate 3 Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.华法林与阿司匹林联用对比单用华法林用于植入HeartMate 3左心室辅助装置患者的疗效：一项系统评价与Meta分析
Pacing Clin Electrophysiol. 2025 Jan;48(1):53-58. doi: 10.1111/pace.15110. Epub 2024 Nov 20.
7
Antithrombotic therapy in heart failure: a randomized comparison of warfarin vs. aspirin (HELAS).
Eur J Heart Fail. 1999 Dec;1(4):419-23. doi: 10.1016/s1388-9842(99)00055-0.
8
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.抗血小板药物与对照或抗凝治疗用于窦性心律心力衰竭的疗效比较：一项Cochrane系统评价
QJM. 2002 Jul;95(7):461-8. doi: 10.1093/qjmed/95.7.461.
9
Antithrombotic therapy for the CardioWest temporary total artificial heart.CardioWest临时全人工心脏的抗栓治疗
Tex Heart Inst J. 2010;37(2):149-58.
10
Antiplatelet agents and anticoagulants for hypertension.抗血小板药物和抗凝剂治疗高血压。
Cochrane Database Syst Rev. 2022 Jul 28;7:CD003186. doi: 10.1002/14651858.CD003186.pub4.
本文引用的文献
1
Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices: The DOAC LVAD Study.评估直接口服抗凝药阿哌沙班在左心室辅助装置中的血液相容性：DOAC-LVAD 研究。
JACC Heart Fail. 2024 Sep;12(9):1540-1549. doi: 10.1016/j.jchf.2024.04.013. Epub 2024 May 7.
2
A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study.一项使用完全磁悬浮左心室辅助装置进行直接口服抗凝治疗的前瞻性随机试验：DOT-HM3研究。
Circulation. 2024 Aug 6;150(6):509-511. doi: 10.1161/CIRCULATIONAHA.124.069726. Epub 2024 Apr 9.
3
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
4
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.阿司匹林与左心室辅助装置在晚期心力衰竭中的血液相容性事件：ARIES-HM3 随机临床试验。
JAMA. 2023 Dec 12;330(22):2171-2181. doi: 10.1001/jama.2023.23204.
5
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update.《2023年国际心肺移植学会机械循环支持指南：十年更新》
J Heart Lung Transplant. 2023 Jul;42(7):e1-e222. doi: 10.1016/j.healun.2022.12.004. Epub 2023 May 25.
6
Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.识别风险患者：HeartMate 3 和 HeartWare 左心室辅助设备的多中心比较。
ESC Heart Fail. 2023 Jun;10(3):1656-1665. doi: 10.1002/ehf2.14308. Epub 2023 Feb 16.
7
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.在 MOMENTUM 3 随机试验中，完全磁悬浮与轴流左心室辅助装置患者的 5 年结果。
JAMA. 2022 Sep 27;328(12):1233-1242. doi: 10.1001/jama.2022.16197.
8
Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.左心室辅助装置治疗的趋势和结果：美国心脏病学会焦点研讨会。
J Am Coll Cardiol. 2022 Mar 22;79(11):1092-1107. doi: 10.1016/j.jacc.2022.01.017.
9
Apixaban: Alternative Anticoagulation for HeartMate 3 Ventricular Assist Device.阿哌沙班：心脏助手 3 心室辅助装置的另一种抗凝选择。
ASAIO J. 2022 Mar 1;68(3):318-322. doi: 10.1097/MAT.0000000000001650.
10
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.VTE疾病的抗栓治疗：CHEST指南及专家小组报告的第二次更新
Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 2.
Zotero 插件